Your browser doesn't support javascript.
loading
Association of a Genetic Variant in the Cyclin-Dependent Kinase Inhibitor 2B with Risk of Pancreatic Cancer.
Sardarzadeh, Newsha; Khojasteh-Leylakoohi, Fatemeh; Damavandi, Sedigheh; Khalili-Tanha, Ghazaleh; Dashtiahangar, Mohammad; Khalili-Tanha, Nima; Avan, Amir; Amoueian, Sakineh; Hassanian, Seyed Mahdi; Esmaily, Habibollah; Khazaei, Majid; Ferns, Gordon; Khooei, Alireza; Aliakbarian, Mohsen.
Afiliação
  • Sardarzadeh N; Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Khojasteh-Leylakoohi F; Metabolic syndrome Research center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Damavandi S; Basic Medical Sciences Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Khalili-Tanha G; Metabolic syndrome Research center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Dashtiahangar M; Basic Medical Sciences Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Khalili-Tanha N; Medical Genetics Research center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Avan A; Metabolic syndrome Research center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Amoueian S; Metabolic syndrome Research center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Hassanian SM; Metabolic syndrome Research center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Esmaily H; Basic Medical Sciences Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Khazaei M; Medical Genetics Research center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Ferns G; Department of Medical Genetics and Molecular Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Khooei A; Department of Pathology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Aliakbarian M; Metabolic syndrome Research center, Mashhad University of Medical Sciences, Mashhad, Iran.
Rep Biochem Mol Biol ; 11(2): 336-343, 2022 Jul.
Article em En | MEDLINE | ID: mdl-36164638

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article